青蒿素（黄花蒿素）：化学与药理学。
Qinghaosu (artemisinin): chemistry and pharmacology.
机构信息
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China.
出版信息
Acta Pharmacol Sin. 2012 Sep;33(9):1141-6. doi: 10.1038/aps.2012.104. Epub 2012 Aug 27.
Abstract
Qinghaosu and its derivatives are widely used in the world as a new generation of antimalarial drug. Up to now, some important progresses of Qinghaosu research have been made, including synthesis of new qinghaosu derivatives and analogs, investigation on their bioactivities and mode of actions. The present review briefly describes these efforts made by researchers in China, particularly in this Institute.
摘要
青蒿素及其衍生物在世界范围内广泛用作新一代抗疟药物。到目前为止，青蒿素的研究已经取得了一些重要进展，包括新的青蒿素衍生物和类似物的合成、它们的生物活性和作用模式的研究。本文简要描述了中国研究人员，特别是本研究所的研究人员在这方面所做的努力。
相似文献
1
Qinghaosu (artemisinin): chemistry and pharmacology.青蒿素（黄花蒿素）：化学与药理学。
Acta Pharmacol Sin. 2012 Sep;33(9):1141-6. doi: 10.1038/aps.2012.104. Epub 2012 Aug 27.
2
An over four millennium story behind qinghaosu (artemisinin)--a fantastic antimalarial drug from a traditional chinese herb.青蒿素背后跨越四千多年的故事——一种源自传统中草药的神奇抗疟药物。
Curr Med Chem. 2003 Nov;10(21):2197-230. doi: 10.2174/0929867033456710.
3
Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.青蒿素及其衍生物作为抗疟和抗肿瘤药物的最新进展。
Curr Med Chem. 2004 May;11(10):1265-84. doi: 10.2174/0929867043365233.
4
Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.青蒿素及其衍生物：一类新型的抗疟和抗癌药物。
Chem Soc Rev. 2010 Feb;39(2):435-54. doi: 10.1039/b816679j. Epub 2009 Aug 24.
5
How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?中国科学家是如何发现青蒿素并研发其衍生物的？未来的前景如何？
Med Trop (Mars). 1998;58(3 Suppl):9-12.
6
The discovery of Qinghaosu (artemisinin) as an effective anti-malaria drug: A unique China story.青蒿素作为一种有效抗疟药物的发现：一个独特的中国故事。
Sci China Life Sci. 2016 Jan;59(1):81-8. doi: 10.1007/s11427-015-4988-z. Epub 2015 Dec 14.
7
Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.针对恶性疟原虫和HL-60癌细胞的超强C-10碳青霉烯青蒿素二聚体的合成及生物学评价
Bioorg Med Chem. 2009 Feb 1;17(3):1325-38. doi: 10.1016/j.bmc.2008.12.017. Epub 2008 Dec 24.
8
Antitumour and antimalarial activity of artemisinin-acridine hybrids.青蒿素-吖啶杂合物的抗肿瘤和抗疟活性。
Bioorg Med Chem Lett. 2009 Apr 1;19(7):2033-7. doi: 10.1016/j.bmcl.2009.02.028. Epub 2009 Feb 11.
9
[Progress in studies on the artemisinin (qinghaosu)-type antimalarials].[青蒿素类抗疟药的研究进展]
Yao Xue Xue Bao. 1998;33(3):234-9.
10
Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.青蒿素及其衍生物类杂合物：治疗癌症和疟疾的有前途的治疗药物。
Molecules. 2021 Dec 11;26(24):7521. doi: 10.3390/molecules26247521.
引用本文的文献
1
Effects of Pilot Scale Hot Water Extracts on a Model of Dexamethasone-Induced Muscle Loss and Muscle Atrophy in C57BL/6 Mice.中试规模热水提取物对C57BL/6小鼠地塞米松诱导的肌肉损失和肌肉萎缩模型的影响。
Int J Mol Sci. 2025 Apr 12;26(8):3656. doi: 10.3390/ijms26083656.
2
Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways.天然倍半萜内酯的研究进展：通过调节关键信号通路克服癌症耐药性
Cancer Drug Resist. 2025 Mar 24;8:13. doi: 10.20517/cdr.2024.178. eCollection 2025.
3
Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells.双氢青蒿素抑制EphA2/PI3K/Akt通路介导的胶质瘤干细胞恶性行为和血管生成拟态。
Heliyon. 2025 Jan 20;11(3):e42095. doi: 10.1016/j.heliyon.2025.e42095. eCollection 2025 Feb 15.
4
Two-photon NAD(P)H-FLIM reveals unperturbed energy metabolism of Ascaris suum larvae, in contrast to host macrophages upon artemisinin derivatives exposure.与青蒿素衍生物暴露后的宿主巨噬细胞相比，双光子NAD(P)H荧光寿命成像揭示了猪蛔虫幼虫未受干扰的能量代谢。
Sci Rep. 2025 Jan 15;15(1):2056. doi: 10.1038/s41598-025-85780-y.
5
From Traditional Use to Modern Evidence: The Medicinal Chemistry of Antimalarials from Genus .从传统应用到现代证据：来自[属名]的抗疟药物的药物化学
Mini Rev Med Chem. 2025;25(3):208-218. doi: 10.2174/0113895575320559240820113540.
6
In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds.纳米姜黄素和青蒿素活性成分对关节炎患者血清黄嘌呤氧化酶的体外抑制作用。
Molecules. 2023 Jun 29;28(13):5124. doi: 10.3390/molecules28135124.
7
Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress.二氢青蒿素再利用以治疗口腔鳞状细胞癌，与线粒体功能障碍和氧化应激相关。
Oxid Med Cell Longev. 2023 Feb 16;2023:9595201. doi: 10.1155/2023/9595201. eCollection 2023.
8
Therapeutic potential of artemisinin and its derivatives in managing kidney diseases.青蒿素及其衍生物在治疗肾脏疾病中的潜在治疗作用。
Front Pharmacol. 2023 Feb 15;14:1097206. doi: 10.3389/fphar.2023.1097206. eCollection 2023.
9
Arteannuin-B and (3-Chlorophenyl)-2-Spiroisoxazoline Derivative Exhibit Anti-Inflammatory Effects in LPS-Activated RAW 264.7 Macrophages and BALB/c Mice-Induced Proinflammatory Responses via Downregulation of NF-κB/P38 MAPK Signaling.青蒿素-B 和（3-氯苯基）-2-螺噁唑啉衍生物通过下调 NF-κB/P38 MAPK 信号通路抑制 LPS 激活的 RAW264.7 巨噬细胞和 BALB/c 小鼠诱导的促炎反应发挥抗炎作用。
Molecules. 2022 Nov 20;27(22):8068. doi: 10.3390/molecules27228068.
10
Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach.淋巴瘤中的铁死亡：新出现的机制及一种新的治疗方法。
Front Genet. 2022 Nov 3;13:1039951. doi: 10.3389/fgene.2022.1039951. eCollection 2022.
本文引用的文献
1
SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.SM934 通过增强巨噬细胞白细胞介素-10 的产生和抑制致病性 T 细胞的发育来治疗狼疮易感 NZB × NZW F1 小鼠。
PLoS One. 2012;7(2):e32424. doi: 10.1371/journal.pone.0032424. Epub 2012 Feb 28.
2
Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug.青蒿素及其衍生物的抗肿瘤活性：从一种著名的抗疟药物到一种潜在的抗癌药物。
J Biomed Biotechnol. 2012;2012:247597. doi: 10.1155/2012/247597. Epub 2011 Nov 22.
3
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.二氢青蒿素耐药结肠癌细胞系 HCT116/R 的特征。
Mol Cell Biochem. 2012 Jan;360(1-2):329-37. doi: 10.1007/s11010-011-1072-2. Epub 2011 Sep 30.
4
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.口服青蒿素类似物SM934通过抑制Th1和Th17细胞反应改善MRL/lpr小鼠的狼疮综合征。
Arthritis Rheum. 2011 Aug;63(8):2445-55. doi: 10.1002/art.30392.
5
The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells.双氢青蒿素的抗癌活性与诱导结直肠癌细胞 HCT116 中铁依赖性内质网应激有关。
Invest New Drugs. 2011 Dec;29(6):1276-83. doi: 10.1007/s10637-010-9481-8. Epub 2010 Jul 7.
6
The molecular mechanism of action of artemisinin--the debate continues.青蒿素的作用机制——争论仍在继续。
Molecules. 2010 Mar 12;15(3):1705-21. doi: 10.3390/molecules15031705.
7
Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.青蒿素通过其特有的线粒体激活作用直接靶向疟原虫线粒体。
PLoS One. 2010 Mar 8;5(3):e9582. doi: 10.1371/journal.pone.0009582.
8
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells.双氢青蒿素加速 c-MYC 癌蛋白降解并诱导 c-MYC 过表达肿瘤细胞凋亡。
Biochem Pharmacol. 2010 Jul 1;80(1):22-30. doi: 10.1016/j.bcp.2010.02.016. Epub 2010 Mar 3.
9
Subcellular localization of a fluorescent artemisinin derivative to endoplasmic reticulum.荧光青蒿素衍生物的亚细胞定位到内质网。
Org Lett. 2010 Apr 2;12(7):1420-3. doi: 10.1021/ol902890j.
10
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.青蒿素衍生物对前列腺癌细胞凋亡和细胞周期的影响。
Anticancer Drugs. 2010 Apr;21(4):423-32. doi: 10.1097/CAD.0b013e328336f57b.
Zotero 插件